|
|
|
|
|
Scientific Program |
|
Congress Dates: December 1-5, 2008. Sanshui Garden Hotel, Foshan, China
Exhibition Dates: December 1-3, 2008. Sanshui Garden Hotel, Foshan, China |
|
BIT Life Sciences' 1st Annual
World Vaccine Congress 2008
Theme: Build an Olympian Meeting Platform for Future Vaccine World
Congress Dates: December 1-5, 2008. Sanshui Garden Hotel, Foshan, China
Exhibition Dates: December 1-3, 2008. Sanshui Garden Hotel, Foshan, China
Scientific Program
|
Main Conference
Opening Ceremony and Keynote Forum
|
Time |
Activities |
November 30, 2008
Sunday
8:00-20:00
Place:
Lobby, 3F
|
Registration |
December 01, 2008
Monday
08:20-11:35
Place:
International Conference Hall, 3F
|
Opening Ceremony and Keynote Forum |
08:20-08:40 Group Photo
09:00-09:45 Opening Ceremony |
Keynote Forum: |
09:50-10:25 |
Title: Polysaccharide-based Conjugate Vaccines for Enteric Bacterial Infections and Group B Meningococci
Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA |
10:25-11:00 |
Title: Typhoid Vaccines asRoutine Public Health Tools for Developing Countries: An Idea Whose Time has Come
Dr. John D. Clemens, Director General, International Vaccine Institute (IVI), Korea |
11:00-11:35 |
Title: Innovation and Strategic Partnerships - Key to Success
Dr. Katherine Cohen, VP, Corporate & Business Development, Intercell AG, Austria |
December 01, 2008
Monday
18:30-20:30
Place:
International Banquet Hall, 3F
|
Welcome Banquet |
Track 1: Public Health, Economics, Safety/Ethic and Policy of Vaccination
¡¡¡¡¡¡¡¡-- How to Turn the Gift of Vaccinations into Being Best Applied to Mankind
|
Track 1-1: Public Health and New Vaccines Developed in Asia and other Developing Countries |
13:30-15:10; December 1, 2008 (Monday)
Place:
Conference room I-1 |
Session Chair |
Dr. Michael O. Favorov, VIVA Program Director , International Vaccine Institute£¬Korea |
Co-Chair |
Dr. Craig Burgess, Senior Programme Officer, GAVI Secretariat, Switzerland |
13:30-14:00 |
Keynote Speech:
Title: Hepatitis E: the Beginning of Vaccination Time
Dr. Michael O. Favorov, VIVA Program Director , International Vaccine Institute, Korea |
14:05-14:35 |
Title: The GAVI Alliance - an Innovative Public Private Partnership to Help Make New and under Utilized Vaccines Available to the Poorest Countries of the World.
Dr. Craig Burgess, Senior Programme Officer, GAVI Secretariat, Switzerland |
14:40-15:10 |
Title: The Critical Path for Vaccine Introduction: An Analysis Based upon the Rapid Introduction of Rotavirus Vaccines into Mexico and Brazil
Dr. Julia Walsh, Researcher, School of Public Health , University of California , Berkeley , USA
|
15:10-15:30 |
Tea Break |
|
Track 1-2: Safety Issues at Individual and Population Level toward Public Acceptance |
13:30-15:10; December 1, 2008 (Monday)
Place:
Conference room I-2
|
Session Chair |
Mohammad Ali, Senior Scientist, International Vaccine Institute, SNU Research Park, Korea |
Co-Chair |
Dr. Shousun C. Szu, Senior scientist, National Institute of Child Health & Human Development, NIH , USA |
13:30-13:55 |
Keynote Speech:
Title: Safety Issues at Individual and Population Level toward Public Acceptance
Dr. Barbara Rath, Department of Pediatrics, Medical University of Vienna, Austria |
13:55-14:20 |
Title: Modelling Spatial Heterogeneity of Disease Risk and Evaluation of The Impact of Vaccination
Dr. Mohammad Ali, Senior Scientist, International Vaccine Institute, SNU Research Park, Korea |
14:20-14:45 |
Title: The impact of Vi Vaccination in a High Typhoid Endemic Region in Southwestern China (Guangxi) from 1995 to 2007 ¨C an Indication of Herd Immunity and Elimination of Typhoid Fever
Dr. Shousun C. Szu, Senior scientist, National Institute of Child Health & Human Development, NIH, USA |
14:45-15:10 |
Title: Adverse Events Following Immunization Surveillance in Europe Results of The Venice Project Survey and Proposals
Dr. Giuseppe Tridente, Professor of Immunology, University of Verona, and The Green Channel Regional Centre for Vaccine Surveillance, Veneto, Italy |
15:10-15:30 |
Tea Break |
|
Track 1-3: History and Past, Present and Possible Future Achievements of Vaccination |
13:30-16:45; December 1, 2008 (Monday)
Place:
Conference room I-3
|
Session Chair |
Dr. Francis E Andre, Consultant in Vaccinology, Ex-Vice President and Senior Medical Director, GlaxoSmithKline Biologicals, Belgium |
Co-Chair |
Dr. Liang Xiaofeng, Director, National Immunization Programme, Chinese Center for Disease Control and Prevention, China |
13:30-13:55 |
Keynote Speech:
Title: The Contribution of China to the Concept of Immunity and its Achievements and Prospects in Disease Prevention
Dr. Liang Xiaofeng, Director, National Immunization Programme Chinese Center for Disease Control and Prevention, China |
13:55-14:20 |
Title: Innovative Approaches to Prevent and Treat Severe Influenza
Dr. Jaap Goudsmit, Chief Scientific Officer, Crucell NV, The Netherlands |
14:20-14:45 |
Title: Edward Jenner: Vacca to Vaccination, the Demise of Smallpox
Dr. Sarah Parker, Director, The Edward Jenner Museum, United Kingdom |
14:45-15:10 |
Title: Louis Pasteur's Contribution to Immunization
Dr. Herve Bazin, Emeritus Professor, University of Louvain, Belgium |
15:10-15:30 |
Tea Break |
15:30-15:55 |
Title: Opposition to Vaccination: When, Who, Why and What
Dr. Francis E Andre, Consultant in Vaccinology, Ex-Vice President and Senior Medical Director, GlaxoSmithKline Biologicals, Belgium |
15:55-16:20 |
Title: New Technologies for Developing Vaccines
Dr. Alberta Di-Pasquale, Director Global Medical Affairs GlaxoSmithKline Biologicals, Belgium |
16:20-16:45 |
Title: The Revolution in Global Immunization
Dr. Mark Kane, Consultant in Vaccinology, USA |
|
Track 2: Scientific & Technological Frontiers of Vaccines
¡¡¡¡¡¡¡¡-- Knowledge Empowers Vaccine Discovery |
Track 2-1: Other Omics in Vaccinology |
15:30-16:40; December 1, 2008 (Monday)
Place:
Conference room I-1 |
Session Chair |
Dr. Michael O. Favorov, VIVA Program Director , International Vaccine Institute£¬Korea |
Co-Chair |
Dr. John W. Cherwonogrodzky, Defence R&D Canada ¨C Suffield, Department of National Defence, Canada |
15:30-16:00 |
Title: Glycomics. A Single Subcellular Vaccine that Protects Mice from Brucella abortus, B.melitensis and B. suis
Dr. John W. Cherwonogrodzky, Defence R&D Canada ¨C Suffield, Department of National Defence, Canada |
16:05-16:40 |
Title: Development of Animal Vaccines for Exo-parasite Control Based on Proteomic Strategies
Dr. Luiz Ricardo Goulart, Professor, The Institute of Genetics and Biochemistry, the Federal University of Uberlandia, Brazil |
|
Track 2-2: Computational Vaccinology: Bioinformatics, Structural Biology and Immunogen Design |
15:30-16:05; December 1, 2008 (Monday)
Place:
Conference room I-2 |
Session Chair |
Dr. Erwin L Roggen, Science Manager, Novozymes A/S, Denmark |
Co-Chair |
Dr. Shousun C. Szu, Senior scientist, National Institute of Child Health & Human Development, NIH, USA |
15:30-16:05 |
Title: Genomic, Immunological and Bioinformatic Approach for Developing HIV Vaccine
Dr. Vidhya Ramaswamy, Director, Yeshwant Advanced Centre for Bioinformatics and Biotechnoogy, India |
|
Track 2-3: Computer Aided Structure Based Vaccine Design |
16:05-16:40;
December 1, 2008 (Monday)
Place:
Conference room I-2 |
Session Chair |
Dr. Erwin L Roggen, Science Manager, Novozymes A/S, Denmark |
Co-Chair |
Dr. Shousun C. Szu, Senior scientist, National Institute of Child Health & Human Development, NIH, USA |
16:05-16:40 |
Title: Discovering Novel B-cell Epitopes by Three-dimensional Modeling
Dr. Erwin L Roggen, Science Manager, Novozymes A/S, Denmark |
|
Track 2-4: Infectious Immunology, Immunity and Vaccinology |
08:30-10:10; December 2, 2008 (Tuesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Claude Nicolau, Professor, Fridman School of Nutrition Science and Policy, Tufts University, USA; CSO, OxyPlus Inc., France |
Co-Chair |
Dr. Joshy Jacob, Associate Professor, Emory University, USA |
08:30-08:55 |
Keynote Speech:
Title: The Action of Anti Infective Vaccines
Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA |
08:55-09:20 |
Title: Immune Responses to Influenza Viruses
Dr. Joshy Jacob, Associate Professor, Emory University, USA |
09:20-09:45 |
Title: The Evaluation of Antibody Responses to Rabies Virus Using Retroviral Pseudotypes and the Implications for ¡®In-Field¡¯ Vaccine Trials
Dr. Edward Wright, Research Fellow, University College London, UK |
09:45-10:10 |
Title£ºThe Quest for an Anti-disease Vaccine Against Trypanosomosis: Effects of Adjuvants on Immune Response to Congopain in Mice and Cattle
Dr. John Kateregga, Lecturer, Makerere University, Uganda |
10:10-10:30 |
Tea Break |
|
Track 2-5: Advances in Molecular and Cell Vaccinology |
10:30-12:10; December 2, 2008 (Tuesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Claude Nicolau, Professor, Fridman School of Nutrition Science and Policy, Tufts University, USA; CSO, OxyPlus Inc., France |
Co-Chair |
Dr. Joshy Jacob, Associate Professor, Emory University, USA |
10:30-10:55 |
Keynote Speech:
Title: Liposomes as Adjuvants and ¡° Keepers ¡° of Antigen Conformation in Vaccines
Dr. Claude Nicolau, Professor, Fridman School of Nutrition Science and Policy, Tufts University, USA; CSO, OxyPlus Inc., France |
10:55-11:20 |
Title: Molecular and Immunological Strategies to Improve the Treatment of Snake Bite
Dr. Robert A Harrison, Senior Lecturer, Head, Alistair Reid Venom Research Unit, Liverpool School of Tropical Medicine , UK |
11:20-11:45 |
Title: Immunogenicity and Safety of Live Attenuated Hepatitis A Vaccine: A Multicentric Study in India
Dr. M.M.A. Faridi,Professor and Head £¬ Department of Pediatrics £¬ University College of Medical Science and GTB Hospital New Delhi , India
|
11:45-12:10 |
Title: Cellular and Humoral Immune Responses to Trivalent Inactivated or Live Attenuated Influenza Vaccine in Healthy Young Adults
Dr. Yuping Deng , Associate Professor, Eastern Virginia Medical School, Norfolk , Virginia , USA |
|
Track 2-6: Applied Toxicology in Vaccinology |
08:30-09:00; December 2, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. David Nalin, Former Director, Vaccine Scientific Affairs. Merck Vaccine Division, Merck&Co. Inc., West Point, Pensylvania, USA |
Co-Chair |
Dr. Nikola Stambuk, Rudjer Boskovic Institute, Croatia |
08:30-09:00 |
Title: Molecular Recognition Theory and its Application in Vaccine Development and Toxicology
Dr. Nikola Stambuk, Rudjer Boskovic Institute, Croatia |
|
Track 2-7: Molecular Microbiology/Virology, and Cell Biology in Vaccinology |
09:05-09:35; December 2, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. David Nalin, Former Director, Vaccine Scientific Affairs. Merck Vaccine Division, Merck&Co. Inc., West Point, Pensylvania, USA |
Co-Chair |
Dr. Nikola Stambuk, Rudjer Boskovic Institute, Croatia |
09:05-09:35 |
Title: HIV-1 Nef is a Critical Regulator of PD-1 Upregulation during HIV-1 Infection
Dr. K. Muthumani, Assistant Professor, University of Pennsylvania School of Medicine, USA |
|
Track 2-8: Evidence-based Vaccinology (EBV) |
09:40-12:10; December 2, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. David Nalin, Former Director, Vaccine Scientific Affairs. Merck Vaccine Division, Merck&Co. Inc., West Point, Pensylvania, USA |
Co-Chair |
Dr. Ioan Stelian Bocsan, Professor of Epidemiology, University of Medicine and Pharmacy, Romania |
09:40-10:10 |
Keynote Speech:
Title: Etiology, Epidemiology and Public Urgent Preparedness
Dr. James J. James, Director, AMA Center for Public Health Preparedness and Disaster Response,USA |
|
Tea Break |
10:30-11:00 |
Title: Marketing and Efficiency in Continuing Medical Education on Immunizations
Dr. Ioan Stelian Bocsan, Professor of Epidemiology, University of Medicine and Pharmacy, Romania |
11:05-11:35 |
Title: Generating Concepts for Evidence-based Action towards Accurate AEFI Reporting while Strengthening Trust in Vaccines
Dr. Barbara A. Rath, Department of Pediatrics Medical University of Vienna Waehringer, Austria |
11:40-12:10 |
Title: Young adults as a Target Group for the Influenza Vaccination.
Dr. Andrzej Ciszewski , Assistant Professor, Institute of Cardiology , Warsaw , Poland |
|
Track 2-9: Emerging Vaccine Development Technologies |
13:30-15:10; December 2, 2008 (Tuesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Jonathan Liu, Director, Research and Development, MedImmune LLC, AstraZeneca, USA |
Co-Chair |
Dr. K. Muthumani, Research Assistant Professor, University of Pennsylvania School of Medicine, USA |
13:30-13:55 |
Keynote Speech:
Title: Innovation For New Vaccine
Dr. Luc Aujame, Director of E R&D, Sanofi Pasteur, France |
13:55-14:20 |
Title: Cell Culture-based Vaccine: An Alternative to Egg-derived Influenza Vaccine and Its Business and Operational Values
Dr. Jonathan Liu , Director, Research and Development, MedImmune LLC, AstraZeneca, USA |
14:20-14:45 |
Title: Innovative Polymeric Adjuvant for Pig Vaccines
Dr. Fabien Bonhoure, Manager, Human Adjuvants and Injectables Department, Seppic S.A., France |
14:45-15:10 |
Title: Inhibiting the Inhibitor: A Novel Approach to Vaccine and Adjuvant Development
Dr. Keyong Ren, CEO,ImmunoVentis, Inc. China
|
15:10-15:30 |
Tea Break |
|
Track 2-10: DNA Based Vaccines and Technologies |
15:30-16:20; December 2, 2008 (Tuesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Peter Loudon, Research Fellow, Pfizer Vaccines Research, Sandwich, UK |
Co-Chair |
Dr. Wei Kong, Research Scientist, Arizona State University, USA |
15:30-15:55 |
Title:Delivery of DNA Vaccine Using Genetically Engineered Self-destruct Salmonella
Dr. Wei Kong, Research Scientist, Arizona State University, USA |
15:55-16:20 |
Title: Particle Mediated Epidermal Delivery of DNA Vaccines for Influenza and HBV - Recent Clinical Data
Dr. Peter Loudon, Research Fellow, Pfizer Vaccines Research, Sandwich, UK |
|
Track 2-11: Adjuvants, Imunopotentiators and Vaccines |
13:30-15:10; December 2, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. Magdalena Plebanski, Head, Vaccine and Infectious Diseases Unit Monash University, Australia |
Co-Chair |
Dr. Hans Netter, Senior Lecturer and Unit Head, Department of Microbiology Clayton Campus, Australia |
13:30-13:50 |
Keynote Speech:
Title: Nanotherapeutics and Disease Preventives: Principles and Challenges
Dr. Magdalena Plebanski, Head, Vaccine and Infectious Diseases Unit Monash University, Australia |
13:50-14:10 |
Title: A Flexible Nanovaccine Approach to Target Protein, Peptide and DNA Based Antigens to Dendritic Cells
Dr. Sue Xiang, Project Manager, Vaccine & Infectious Diseases Laboratory, Department of Immunology, Australia |
14:10-14:30 |
Title: Inhibitors of Cysteine Cathepsins Inhibitors Act as Immuno-potentiators by Boosting T Cell Memory
Dr. Ashton-Rickardt, Philip G, Professor, Department of Immunology, Division of Medicine, Imperial College London, UK |
14:30-14:50 |
Title: Chimeric Virus-like Particles for the Delivery of Foreign B-cell and CTL-Epitopes
Dr. Hans Netter, Senior Lecturer and Unit Head, Department of Microbiology Clayton Campus, Australia |
14:50-15:10 |
Title: Adjuvanting a DNA Vaccine With a TLR9 Ligand Plus Flt3 Ligand for Enhanced Cellular Immunity Against SIV
Dr. Marcin Kwissa, immunologist,, Vaccine Research Center and Yerkes National Primate Research Center, USA |
15:10-15:30 |
Tea Break |
|
Track 2-12: Innate Immunity and Novel Vaccines |
15:30-16:45; December 3, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. Alan Shaw, Chief Executive Officer, Vaxinnate Corporation, USA |
Co-Chair |
Dr. Hans Netter, Senior Lecturer and Unit Head, Department of Microbiology Clayton Campus, Australia |
15:30-15:55 |
Keynote Speech:
Title: Flagellin Fusion Vaccines for Influenza
Dr. Alan Shaw,Chief Executive Officer, Vaxinnate Corporation, USA |
15:55-16:20 |
Title: The Use of Small Molecule Toll-like Receptor (TLR)7/8 Agonists as Vaccine Adjuvants
Dr. Mark A. Tomai, Manager, New Business Development & Program Management, 3M Drug Delivery Systems, USA |
16:20-16:45 |
Title: PIKA Adjuvant: A TLR3 Agonist for Prophylactic and Therapeutic Vaccines
Dr. Li Lie Tao, Chief Operating Officer,NewBiomed PIKA Pte. Ltd, Singapore |
|
Track 2-13:Mucosal Immunity and Vaccine Design |
16:20-17:10; December 2, 2008 (Tuesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Peter Loudon, Research Fellow, Pfizer Vaccines Research, Sandwich, UK |
Co-Chair |
Dr. Wei Kong, Research Scientist, Arizona State University, USA |
16:20-16:45 |
Title:Molecular Geometry: New Dimension in the Design of Mucosal Vaccines Against Group A Streptococcal Infection
Dr. Abu-Baker, University of Queensland, Australia |
16:45-17:10 |
Title: Progress in a Mucosally-administered Vaccine against Helicobacter pylori
Dr. Quanming Zou,Professor, Department of Clinical Microbiology and Immunology,
Third Military Medical University, China |
|
Track 2-14: Peptide Based Vaccines and Peptide MHC Interactions to Aid in Better Vaccines |
16:45-17:10; December 2, 2008 (Tuesday)
Place:
Conference room I-2 |
Session Chair |
Dr. Alan Shaw, Chief Executive Officer, Vaxinnate Corporation, USA |
Co-Chair |
Dr. Hans Netter, Senior Lecturer and Unit Head, Department of Microbiology Clayton Campus, Australia |
16:45-17:10 |
Title: CD4 Helper Independent Vaccine for Chronic Infectious Diseases and Cancers
Dr. Qibin Leng, Professor, Institut Pasteur of Shanghai, China |
|
Track 2-15: Cytokine Networks in Vaccine Design |
08:30-09:35; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Andrew Lloyd, Professor, Centre for Infection and Inflammation Research (CIIR), School of Medical Sciences, University of New South Wales, Australia |
Co-Chair |
Dr. Goutam Gupta, Researcher, Biosciences Division, Group B-1, Los Alamos National Laboratory, USA |
08:30-09:00 |
Keynote Speech:
Title: Anti-carbohydrate specific immune response and tumor cell lysis correlate with vaccination-induced synchronized release of stimulatory cytokines
Dr. Kircheis Ralf, Founder/Chief Scientific Officer of Vela Laboratories, Austria |
09:05-09:35 |
Title: Assessing Immunity by Flow CytometryAsAsss
Dr. Andreas Thiel, Group Leader Clinical Immunology, DRFZ Berlin, Germany |
|
Track 2-16: Overcome the Barriers of Vaccines Formulation and Delivery |
08:30-10:10; December 3, 2008 (Wednesday)
Place:
Conference room I-2 |
Session Chair |
Dr. David R. Nalin, Retired Director,Vaccine Scientific Affairs, Merck Vaccine Division, Consultant in Vaccinology, USA |
Co-Chair |
Dr. Dennis J. Kopecko , Chief, Lab of Enteric Diseases, US FDA-CBER, USA |
08:30-08:55 |
Keynote Speech:
Title: Development of Polyphosphazene Vaccine Delivery Systems
Dr. Alexander K. Andrianov, Vice President, Research & Development£¬Apogee Technology, Inc.USA |
08:55-09:20 |
Title: Proposal for a Novel Concept of Vaccination.
Dr. David R. Nalin, Retired Director,Vaccine Scientific Affairs, Merck Vaccine Division, Consultant in Vaccinology, USA |
09:20-09:45 |
Title: Oral Live, Attenuated Typhoid-Shigella Multivalent Vaccine Development
Dr. Dennis J. Kopecko , Chief, Lab of Enteric Diseases, US FDA-CBER, USA |
09:45-10:10 |
Title:Nasal Immunization in Rabbits by Alginate Microspheres Encapsulated with Tetanus Toxoid and Quillaja Saponins
Dr. Mohsen Tafaghodi, Assistant Professor, Mashhad School of Pharmacy, Iran |
10:10-10:30 |
Tea Break |
|
Track 3: Human Preventive and Therapeutic Vaccines-Future Vaccines
¡¡¡¡¡¡¡¡-- Fueling Your Pipeline for the Future Vaccines |
|
Track 3-1: Rational Applications of Vaccines for Different Disease States |
09:40-11:00; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Andrew Lloyd, Professor, Centre for Infection and Inflammation Research (CIIR), School of Medical Sciences, University of New South Wales, Australia |
Co-Chair |
Dr. Goutam Gupta, Researcher, Biosciences Division, Group B-1, Los Alamos National Laboratory, USA |
09:40-10:10 |
Keynote Speech:
Title: Virosomal Hepatitis A Vaccine: How Long can We Delay the Booster Dose
Dr. Olga Popova, Director Government Affairs, Crucell, Switzerland |
10:10-10:30 |
Tea Break |
10:30-11:00 |
Title: A Dual-Purpose Protein Ligand For Effective Therapy and Sensitive Diagnosis of Anthrax
Dr. Goutam Gupta, Researcher, Biosciences Division, Group B-1, Los Alamos National Laboratory, USA |
|
Track 3-2: Research Progress of HIV Vaccination |
11:05-11:35; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Andrew Lloyd, Professor, Centre for Infection and Inflammation Research (CIIR), School of Medical Sciences, University of New South Wales, Australia |
Co-Chair |
Dr. Goutam Gupta, Researcher, Biosciences Division, Group B-1, Los Alamos National Laboratory, USA |
11:05-11:35 |
Title: Efficacy of Silver Nanoparticles in Neutralizing HIV-1 Infectivity
Dr. Dinesh K. Singh, Assistant Professor, Winston Salem State University, USA |
|
Track 3-3: Anti-HIV Vaccine Discovery and Development |
08:30-11:00; December 3, 2008 (Wednesday)
Place:
Conference room I-3 |
Session Chair |
Dr. R Holland Cheng, Professor of Molecular and Cellular Biology
Director, PIOMS Institutional Program, University California, USA |
Co-Chair |
Dr. Paolo Monini, Director, Division of Virus-Host Interaction and Core-Laboratory of Immunology, National AIDS Center , Italy |
08:30-09:00 |
Keynote Speech:
Title:Pediatric HIV Clinic Trials: The Time Has Come!
Dr. Cheryl Pikora, Associate Medical Director, Kendle International, Inc. USA |
09:05-09:35 |
Title: HIV-1 Env and Tat Interact to Form a Novel Virus Entry Complex Which Directs the Virus to RGD-Binding Integrins
Dr. Paolo Monini, Director, Division of Virus-Host Interaction and Core-Laboratory of Immunology, National AIDS Center, Italy |
09:40-10:10 |
Title: Spatial Configuration of High-affinity Receptor Mimics on Viral Entry
Dr. R Holland Cheng, Professor of Molecular and Cellular Biology, University California, Davis CA, USA |
10:10-10:30 |
Tea Break |
10:30-11:00 |
Title: Neutralization of HIV-1 by Redirection of Natural Antibodies
Dr. Anders Vahlne, Professor, Division of Clinical Microbiology, Karolinska Institutet, F-68 Karolinska University Hospital at Huddinge , Sweden |
|
Track 3-4: Anti HCV Vaccine Discovery and Development |
11:40-12:10; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Andrew Lloyd, Professor, Centre for Infection and Inflammation Research (CIIR), School of Medical Sciences, University of New South Wales, Australia |
Co-Chair |
Dr. Goutam Gupta, Researcher, Biosciences Division, Group B-1, Los Alamos National Laboratory, USA |
11:40-12:10 |
Title: Hepatitis C Vaccine Preparedness: Identifying Cohorts at Risk
Dr. Andrew Lloyd, Professor, Centre for Infection and Inflammation Research (CIIR), School of Medical Sciences, University of New South Wales, Australia |
|
Track 3-5: Vaccine Design against Microbial Pathogens and Severe Bacterial Infections |
13:30-14:00; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Joseph Lustgarten, Associate Professor, Department of Immunology, Cancer Center Scottsdale, Mayo Clinic Arizona, USA |
Co-Chair |
Dr. Liu Li-Hua, Professor, the First Hospital of Jilin University , China |
13:30-14:00 |
Title: A Novel Mucosal Immunization Platform Based on Pentameric Single Domain Antibody
Dr. Jianbing Zhang, Institute for Biological Sciences National Research Council of Canada , Canada
|
|
Track 3-6: Tumor Immunology, Immunotherapy with Cancer Vaccines |
14:05-17:10; December 3, 2008 (Wednesday)
Place:
Conference room I-1 |
Session Chair |
Dr. Joseph Lustgarten, Associate Professor, Department of Immunology, Cancer Center Scottsdale, Mayo Clinic Arizona, USA |
Co-Chair |
Dr. Liu Li-Hua, Professor, the First Hospital of Jilin University, China |
14:05-14:35 |
Keynote Speech:
Title: Ceramide 1-phosphate: A Novel Promoter of Cell Growth and Survival
Dr. Antonio Gomez-Munoz, Professor, Departmentof Biochemistry and Molecular Biology. University of the Basque Country, Spain |
|
Title: Antibody-CpG-ODN Hybrid Molecules for the Systemic Target and Induction of Antitumor Responses in Young and Old Tumor Bearing Hosts
Dr. Joseph Lustgarten, Associate Professor, Department of Immunology, Cancer Center Scottsdale , Mayo Clinic Arizona, USA |
15:10-15:30 |
Tea Break |
15:30-15:55 |
Title: Development of a Fdxion Gene Vaccine Composed of Encoding Sequence for Tandem Repeats of CEA625-667 Epitopes and MtHSP 70C
Dr. Liu Li-Hua, Professor, the First Hospital of Jilin University , China |
15:55-16:20 |
Title: Experience in Treating Spontaneous Tumor-Bearing Dogs Using Electroporaton Vaccine
Dr. Shulin Li, Professor, Comparative Biomedical Sciences, Louisiana State University, USA |
16:20-16:45 |
Title: ISCOMATRIXTM Adjuvant Targets Tumor Antigen Efficiently to Cross-presentation Pathway and Induce Broad CD4+ and CD8+ T cell Responses in Humans
Dr. Weisan Chen, Professor, Melbourne University, Associate Member of Ludwig Institute for Cancer Research, Australia |
16:45-17:10 |
Title: DNA-mediated Activation of Innate Immune Responses; Its Possible Involvement in Tumor Immunity
Dr. Akinori Takaoka, Professor, Hokkaido University, Japan |
|
Track 3-7: Advances in Cancer Vaccine Technology |
13:30-16:35; December 3, 2008 (Wednesday)
Place:
Conference room I-2 |
Session Chair |
Dr. Laiqiang Huang, Professor & Director, The Shenzhen Key Lab of Gene & Antibody Therapy, Center for Biotech & BioMedicine and Div of Life Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China. |
Co-Chair |
Dr. Fabien Bonhoure, Project Manager, Human Adjuvants and Injectables Department, Seppic S.A., France |
13:30-14:00 |
Keynote Speech:
Title: Tumor Microenvironment, Inflammation and Anticancer Vaccines: Looking for New Perspectives
Dr. Luca Vannucci, Institute of Microbiology, Dept. of Immunology and Gnotobiology, Academy of Sciences of the Czech Republic, Czech Republic |
14:05-14:35 |
Title: Therapeutic Cervical Cancer Vaccines: Enhancement of Immunotherapeutic Effects of HPV16E7 by Fusion with CTLA4
Dr. Laiqiang Huang, Professor & Director, The Shenzhen Key Lab of Gene & Antibody Therapy, Center for Biotech & BioMedicine and Div of Life Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China. |
14:40-15:10 |
Title: Selection of Ideal Particle Size for W/O Emulsions Based Vaccine
Dr. Fabien Bonhoure, Project Manager, Human Adjuvants and Injectables Department, Seppic S.A., France |
15:10-15:30 |
Tea Break |
15:30-16:00 |
Title: Therapeutic Liver Cancer Vaccines: A Gene-Based and Tumor Cell Membrane-Anchored Vaccine against Hepatocellular Carcinoma
Dr. Dongye Yang, Associate Professor, Department of Gastroenterology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China; Senior Visiting Scholar, Center for Biotech & BioMedicine, Tsinghua University Graduate School at Shenzhen, Guangdong, China |
16:05-16:35 |
Title: Therapeutic Cervical Cancer Vaccines: Viral Vector-Based Multivalent HPV Vaccine and Enhancement by SOCS1-Silencing
Dr. Yi Zheng, Associate Professor, Center for Biotech & BioMedicine and Shenzhen Key Lab of Gene & Antibody Therapy, Tsinghua University Graduate School at Shenzhen, Guangdong, China |
|
Track 3-8: Vaccine Development for Severe Gastrointestinal Disorders & Enteric Infectious Diseases |
08:30-11:40; December 4, 2008 (Thursday)
Place:
Conference room I-1 |
Session Chair |
Dr. Francis E Andre, Consultant in Vaccinology, Ex-Vice President and Senior Medical Director, GlaxoSmithKline Biologicals, Belgium |
Co-Chair |
Dr. Jose A. Chabalgoity, Professor, Department of Biotechnology, School of Medicine, Uruguay |
08:30-09:00 |
Keynote Speech:
Title: How Rotavirus Vaccines Were Developed and Their Potential Future Impact
Dr. Francis E Andre, Consultant in Vaccinology, Ex-Vice President and Senior Medical Director, GlaxoSmithKline Biologicals, Belgium |
09:05-09:35 |
Title: Safety and Immunogenicity of Typhoid Vi Conjugate Vaccine in Young Children and in Infants Administered in Concurrently with DPT
Dr. Shousun C. Szu, Senior scientist, National Institute of Child Health & Human Development, NIH, USA |
09:40-10:10 |
Title: Vaccine Design Against Shigellosis (Bacillary Dysentery)
Dr. Naresh Verma, School of Biochemistry and Molecular Biology, College of Science, The Australian National University, Australia |
10:10-10:30 |
Tea Break |
10:30-11:00 |
Title: Salmonella Vectors Coming of Age for New Vaccines Development
Dr. Jose A. Chabalgoity, Professor, Department of Biotechnology, School of Medicine, Uruguay |
11:05-11:35 |
Title: A Subunit Vaccine against Typhoid: Identification, Cloning and Expression and Immunological Evaluation of a Novel Protein from Outer Membranes of Salmonella
Dr. SK Jain, Professor of Biotechnology, Dean, Faculty of Science, Hamdard University, India |
|
Track 3-9: Vaccine Development for Cardiovascular Diseases |
11:40-12:10; December 4, 2008 (Thursday)
Place:
Conference room I-1 |
Session Chair |
Dr. Francis E Andre, Consultant in Vaccinology, Ex-Vice President and Senior Medical Director, GlaxoSmithKline Biologicals, Belgium |
Co-Chair |
Dr. Jose A. Chabalgoity, Professor, Department of Biotechnology, School of Medicine, Uruguay |
11:40-12:10 |
Title£ºTherapeutic Vaccines for Hypertension
Dr. Liao Yu-Hua, Professor, Institute of Cardiology, Union hospital of Huazhong University of Science & Technology Wuhan, China |
|
Track 3-10: Vaccination and/against CNS Disorder |
08:30-09:20; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Maurizio Memo, Professor, Department of Biomedical Sciences and Biotechnologies, University of Brescia Medical School, Brescia, Italy |
Co-Chair |
Dr. Beka Solomon, Professor, Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel |
08:30-08:55 |
Keynote Speech:
Title: Molecular and Cellular Evidence Supporting the Immunological Approach for Alzheimer¡¯s Disease: Focus on TNF-related Apoptosis Inducing Ligand (TRAIL)
Dr. Maurizio Memo, Professor, Department of Biomedical Sciences and Biotechnologies, University of Brescia Medical School, Brescia, Italy |
08:55-09:20 |
Title: Immunotherapy of Alzheimer's Disease - Active and Passive Vaccination against Beta-amyloid Peptide
Dr. Beka Solomon, Professor, Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel |
|
Track 3-11: Antigen-specific Immunotherapy and New Vaccine Approaches for Allergies |
09:20-10:10; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Maurizio Memo, Professor, Department of Biomedical Sciences and Biotechnologies, University of Brescia Medical School, Brescia, Italy |
Co-Chair |
Dr. Beka Solomon, Professor, Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel |
09:20-09:45 |
Title: IgE and Th2 Cytokine Peptide-based Virus-like Particle Vaccines in the Down-regulation of Serum IgE and Airway Allergic Inflammation in Mice
Dr. Zhikang Peng, Professor, Departments of Pediatrics and Immunology, University of Manitoba, Canada |
09:45-10:10 |
Title: Recombinant Allergens for Future Component-resolved Diagnosis and Tailor-made Immunotherapy
Dr. Seiji Kawamoto, Associate Professor£¬Department of Molecular Biotechnology£¬ Graduate School of Advanced Sciences of Matter, Hiroshima University, Japan |
10:10-10:30 |
Tea Break |
|
Track 3-12: Vaccine Development for Autoimmune Diseases |
10:30-11:20; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Lance L. Simpson, Director, Center for Research on Bioterrorism and Biodefense, Jefferson Medical College, USA |
Co-Chair |
Dr. Arpad Z. Barabas, Research Scientist, University of Calgary, Canada |
10:30-10:55 |
Title: The Modified Vaccination Technique for the Prevention and Treatment of Chronic Ailments
Dr. Arpad Z. Barabas, Research Scientist, University of Calgary, Canada |
10:55-11:20 |
Title: Group A Streptococci Vaccine: Special Focus on the Control of Autoimmune Reactions
Dr. Luiza GUILHERME, Professor in Immunology, Heart Institute (InCor), School of Medicine, University of So Paulo, Brazil |
|
Track 4: Other Human Vaccine Development
¡¡¡¡¡¡¡¡-- Control Bad Influences and Protect Homeland Security |
|
Track 4-1: Vaccine Development against Bioterrorism |
11:20-12:30; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Lance L. Simpson, Director, Center for Research on Bioterrorism and Biodefense, Jefferson Medical College, USA |
Co-Chair |
Dr. Arpad Z. Barabas, Research Scientist, University of Calgary, Canada |
11:20-11:45 |
Keynote Speech:
Title: Localization of the Sites and Identification of the Mechanisms that Account for Antibody Neutralization of Botulinum Toxin
Dr. Lance L. Simpson, Director, Center for Research on Bioterrorism and Biodefense, Jefferson Medical College, USA |
11:45-12:10 |
Title: Recombinant Anthrax Vaccines for Veterinary Use
Dr. Antonio Fasanella,Anthrax Reference Institute of Italy - Istituto Zooprofilattico Sperimentale of Puglia and Basilicata, Italy |
12:10-12:30 |
Title: Development of Salmonella Typhi Ty 21a -vectored Oral Anthrax Vaccine Candidate
Dr. Dennis J. Kopecko , Chief, Lab of Enteric Diseases, US FDA-CBER , USA |
|
Track 5: Vaccine R & D for Emerging/Re-emerging and other Infectious Diseases
¡¡¡¡¡¡¡¡--Provide Better Cures to Life Threatening Epidemic Diseases |
|
Track 5-1: Influenza, Avian Flu, and SARS Vaccine Development |
13:30-17:10;
Thursday 12/4/2008
Place:Conference room I-1 |
Session Chair |
Dr. Jonathan Liu, Director, Research and Development , MedImmune, LLC. An AstraZenenca Company, USA |
Co-Chair |
Dr. Jiahai Lu, Professor, Sun Yat-sen University, China |
13:30-13:55 |
Keynote Speech:
Title:The Use of Cell Culture for the Development of Avian Influenza and SARS Vaccines
Dr. Peter Khoury, Vice President, Global Marketing Baxter Bioscience-Vaccines, USA |
13:55-14:20 |
Title: Improvement of Vaccine Productivity with Reduced Manufacturing Process Development Time
Dr. Jonathan Liu, Director, Research and Development , MedImmune, LLC. An AstraZenenca Company, USA |
14:20-14:45 |
Title: A Novel Platform for the Evaluation and Characterization of Neutralizing Antibodies against Influenza HA and NA: Implications for Vaccine Development"
Dr. Nigel Temperton , Senior Research Fellow: Emerging Viruses MRC/UCL Centre for Medical Molecular Virology , United Kingdom |
14:45-15:10 |
Title: Influenza Surveillance in Wild Birds in the Western Siberia of 2007
Dr. Shestopalov A.M, Head of Department, State Research Center of Virology and Biotechnology Vector , Russia |
15:10-15:30 |
Tea Break |
15:30-15:50 |
Title: Influenza, Avian Flu and SARS Vaccine Development in China
Dr. Jiahai Lu, Professor, Sun Yat-sen University, China |
15:50-16:10 |
Title: Live Attenuated Influenza Vaccine for Seasonal and Pandemic Preparedness
Dr. Hong Jin, MedImmune Fellow, Sr. Scientist, Research Department, MedImmune , USA |
16:10-16:30 |
Title: Immunological Assays for Influenza Antibodies Detection
Dr. Emanuele Montomoli , Professor, Department of Physiopathology Experimental Medicine, Public Health Lab Molecular Epidemiology - University of Siena , Italy |
16:30-16:50 |
Title: Live Attenuated Vaccine Platform for Seasonal and Pandemic Influenza
Dr. Baik Lin Seong, Professor, Yonsei University, Korea
|
16:50-17:10 |
Title: A Platform to Develop Vaccines Against Avian Influenza and a Vaccine Candidate Against SARS Coronavirus
Dr. Chen Guang,Department of Biological Sciences,
National University of Singapore, Singapore |
|
Track 5-2: TB Vaccine Development: Opportunity and Imperative |
15:30-16:45; Thursday 12/4/2008
Place:
Conference room I-2 |
Session Chair |
Dr. Vijaya Lakshmi Valluri, Group Leader, the Immunology & Molecular Biology Division, India |
Co-Chair |
Dr. Jorge Fernadez de Castro, Investigator, National Institute of Public Health, Mexico |
15:30-15:55 |
Title: Immunogenicity of BCG and Influence of Host Genotypes on Efficacy of Vaccination
Dr. Vijaya Lakshmi Valluri, Group Leader, the Immunology & Molecular Biology Division, India |
15:55-16:20 |
Title: Expression, Immunogenicity and Vaccine Potential of Mycobacterium tuberculosis-specific RD1-Encoded Antigens in Animal Models
Dr. Abu S. Mustafa, Professor, Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait |
16:20 -16:45 |
Title: Identification of Mycobacterium Tuberculosis-specific Antigens to be Included in Improved BCG Vaccine Using Recombinant Mycobacterial Expression System
Dr. Hanady Amoudy, Assistant professor, Kuwait University, Kuwait |
|
Track 5-3: Malaria Vaccine Development |
14:50-15:10; Thursday 12/4/2008
Place:
Conference room I-2 |
Session Chair |
Dr. Annie Mo, Program Officer, Preclinical Vaccine Development, Parasitology & International Program Branch, Division of Microbiology&Infectious Diseases National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health&Human Service, USA |
Co-Chair |
Dr. Jorge Fernadez de Castro, Investigator, National Institute of Public Health, Mexico |
14:50-15:10 |
Title: Malaria Vaccine Research & Development in NIAID Extramural Program
Dr. Annie Mo, Program Officer, Preclinical Vaccine Development, Parasitology & International Program Branch, Division of Microbiology&Infectious Diseases National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health&Human Service, USA |
15:10-15:30 |
Tea Break |
|
Track 5-4: Vaccine Discovery and Development against other Emerging Infectious Diseases |
13:30-14:50; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Annie Mo, Program Officer, Preclinical Vaccine Development, Parasitology & International Program Branch, Division of Microbiology&Infectious Diseases National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health&Human Service, USA |
Co-Chair |
Dr. Jorge Fernadez de Castro, Investigator, National Institute of Public Health, Mexico |
13:30-13:50 |
Keynote Speech:
Title: A Pan-filovirus Vaccine Based on Virus-Like Particles (VLPs)
Dr. Kelly Lyn Warfield, Vice President of Vaccine Development, Integrated BioTherapeutics Inc. USA
|
13:50-14:10 |
Title: A New Route for Measles Vaccination
Dr. Jorge Fernadez de Castro, Investigator, National Institute of Public Health , Mexico
|
14:10-14:30 |
Title: Chikungunya Virus Novel Consensus-based DNA Vaccine Induces Immune Responses in Mice
Dr. Karuppiah Muthumani, Assistant Professor , Dept of Pathology and Lab Medicine, University of Pennsylvania School of Medicine, USA |
14:30-14:50 |
Title: The Quest for an ¡°Anti-disease¡± Vaccine against African Trypanosomosis: Status and Latest Developments
Dr. Alain Boulang¨¦, Visiting Scientist - Dpt BIOS of CIRAD,School of Biochemistry, Genetics, Microbiology and Plant Pathology ,University of KwaZulu-Natal , South Africa |
|
Track 5-5: Vaccine against other Resistant and Multi-Resistant Pathogens |
16:45-17:10; December 4, 2008 (Thursday)
Place:
Conference room I-2 |
Session Chair |
Dr. Vijaya Lakshmi Valluri, Group Leader, the Immunology & Molecular Biology Division, India |
Co-Chair |
Dr. Jorge Fernadez de Castro, Investigator, National Institute of Public Health, Mexico |
16:45-17:10 |
Title: Active Laboratory-based Surveillance for Invasive and Non-invasive Shigellosis in South Africa, 2003 -2007: Predominant Serotypes may Guide Vaccine Development.
Dr. Karen Keddy, Senior consultant, Enteric Diseases Reference Unit & University of the Witwatersrand, South Africa |
|
Track 6: Livestock/ Aquaculture/Veterinary Vaccine Innovations
¡¡¡¡¡¡¡¡-- Overcome Resistance and Increase Productivity |
|
Track 6-1: Veterinary and Aquatic Vaccinology |
13:30-17:10;
December 4, 2008 (Thursday)
Place:
Conference room I-3 |
Session Chair |
Dr. A.E. Metlin, FGI ¡°Federal Centre for Animal Health¡±, Vladimir, Russia |
Co-Chair |
Dr. Zhaoxin Zheng , Professor, State Key Laboratory of Genetic Engineering, Fudan University , China |
13:30-14:00 |
Keynote Speech:
Title: MONTANIDE? ISA 763 A VG Adjuvant for Efficient and Safe Fish Vaccines.
Dr. Fabien Bonhoure, Manager, Human Adjuvants and Injectables Department, Seppic S.A., France |
14:05-14:35 |
Title: Trends and Development of Oral Vaccination Against Rabies in the Russian Federation
Dr. A.E. Metlin , FGI ¡°Federal Centre for Animal Health¡±, Vladimir , Russia |
14:40-15:10 |
Title: Quorum Sensing in Vaccine Production
Dr. F¨¢bio Pereira Leivas Leite, Professor, Federal University of Pelotas , Brazil
|
15:10-15:30 |
Tea Break |
15:30-16:00 |
Title: A Recombinant Vaccine Against Foot-and-mouth Disease Virus and the Adjuvant Stimulus to Immune Response in Swine
Dr. Zhaoxin Zheng , Professor, State Key Laboratory of Genetic Engineering, Fudan University , China
|
16:05-16:35 |
Title: Progress in Veterinary Vaccines: New Concepts & New Trends
Dr. Ajit Singh, Professor, I/C Immunology Section, Department of Veterinary Microbiology, Ch.Charan Singh Haryana Agricultural University, India |
16:40-17:10 |
Title: Field evaluation of local gametocytes vaccine and its comparative efficacy with imported live vaccine, LivaCox ?
Dr. Masood Akhtar, Associate Professor, Department of Parasitology, University of Agriculture , Pakistan |
|
Track 6-2: Latest Breakthrough in Veterinary Vaccine Development |
08:30-09:20; December 5, 2008 (Friday)
Place:
Conference room I-1 |
Session Chair |
Dr. A.E. Metlin, FGI ¡°Federal Centre for Animal Health¡±, Vladimir, Russia |
Co-Chair |
Dr. Aleksei Krasnov, Senior researcher, Nofima Marine, As, Norway |
08:30-08:55 |
Keynote Speech:
Title: Use of Broth Microdilution Method for Identification of Specifically Attenuated Salmonella Enteritidis and S. Typhimurium Vaccine Strains and Overall Antimicrobial Susceptibility Testing in Poultry in Response to the Salmonellosis Regulations of the European Commission
Dr. Dierk Rebeski , Director of R & D Poultry Vaccines, Lohmann Animal Health GmbH & Co. KG, Germany |
08:55-09:20 |
Title: Manufacture and Maintenance of the System of Veterinary Drugs Quality in the Russian Federation
Dr. Alexander N. Panin £¬ Member of the Russian Academy of Agricultural Science , the corresponding member of the France Academy of Veterinary, Russia |
|
Track 6-3: Livestock Vaccines |
09:20-10:30; December 5, 2008 (Friday)
Place:
Conference room I-1 |
Session Chair |
Dr. A.E. Metlin, FGI ¡°Federal Centre for Animal Health¡±, Vladimir, Russia |
Co-Chair |
Dr. Aleksei Krasnov, Senior researcher, Nofima Marine, As, Norway |
09:20-09:45 |
Title: MONTANIDE? PET Gel A, Rising Generation of Polymer Based Adjuvant for Dog Vaccines.
Dr. Fabien Bonhoure, , Manager, Human Adjuvants and Injectables Department, Seppic S.A., France |
09:45-10:10 |
Title: Immunological Studies on Contagious Bovine Pleuropneumonia (CBPP) with a View to Developing an Improved Vaccine Against the Disease
Dr. Mamadou Niang, Senior research scientist and Head of the Diagnostic and Research Department Central Veterinary Laboratory (CVL), Bamako-Mali |
10:10-10:30 |
Tea Break |
|
Track 6-4(Track 6-6): Economic Fish Vaccine Development and Market |
10:30-11:00; December 5, 2008 (Friday)
Place:
Conference room I-1 |
Session Chair |
Dr. A.E. Metlin, FGI ¡°Federal Centre for Animal Health¡±, Vladimir, Russia |
Co-Chair |
Dr. Aleksei Krasnov, Senior researcher, Nofima Marine, As, Norway |
10:30-11:00 |
Title: Microarray Gene Expression Profiling Reveals Protective Responses in Atlantic Salmon Vaccinated against Furunculosis
Dr. Aleksei Krasnov, Senior researcher, Nofima Marine, As, Norway |
|
Track 6-5: Tech Advances in Agricultural/Aquaculture Vaccine Development |
11:05-11:55; December 5, 2008 (Friday)
Place:
Conference room I-1 |
Session Chair |
Dr. A.E. Metlin, FGI ¡°Federal Centre for Animal Health¡±, Vladimir, Russia |
Co-Chair |
Dr. Aleksei Krasnov, Senior researcher, Nofima Marine, As, Norway |
11:05-11:30 |
Title: Vaccines for Warmwater Aquaculture
Dr. Phillip Klesius, Research Leader, U.S. Department of Agriculture, Agricultural Research Service, Aquatic Animal Health Research Laboratory, USA |
11:30-11:55 |
Title: Title: Fish Vaccine Development ¨C Identification of Potential Vaccine Candidates
Dr. Alexandra Adams, Professor, Head of the Aquatic Vaccine Unit at the Institute of Aquaculture , University of Stirling , Chief Executive Director of Aquatic Diagnostics Ltd, UK |
|
|
|
BIT' s Claims: All events BIT Life Sciences organized are purely for promotion of advancement of sciences and technologies for the sustainable development of a healthier and wealthier world. No political, religious racial bias and non-ethic knowledge are accepted through our intelligence exchange platform. Any illegal and offensive Information will be 100% avoided. |
|
|
